Jump Financial, LLC Reata Pharmaceuticals Inc Transaction History

Jump Financial, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$22.15 - $42.11 $476,224 - $905,365	21,500 New	21,500 $816,000
Q4 2021 Feb 10, 2022	SELL	$25.61 - $110.96 $576,225 - $2.5 Million	-22,500 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$100.0 - $143.02 $2.25 Million - $3.22 Million	22,500 New	22,500 $2.26 Million
Q2 2021 Aug 13, 2021	SELL	$78.27 - $151.29 $508,755 - $983,385	-6,500 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$94.25 - $132.81 $612,625 - $863,265	6,500 New	6,500 $648,000

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.